GDF15 and melanoma: We further generated GDF15 knockout cells using CRISPR/Cas9 technology (Fig. 5i; Supplementary Fig. 4f) and found that GDF15 knockout sensitized melanoma cells to sunitinib (Fig. 5j; Supplementary Fig. 4g).